weakly significantp = 0.038
A weakly significant increase in the quality measure for statin therapy in the main analysis (95%CI, 0.0 to 1.8, p = 0.038) became insignificant in the sensitivity analysis (95%CI, 0.2 to 1.6, p = 0.112) ( S3 Table ).
A weakly significant increase in the quality measure for statin therapy in the main analysis (95%CI, 0.0 to 1.8, p = 0.038) became insignificant in the sensitivity analysis (95%CI, 0.2 to 1.6, p = 0.112) ( S3 Table ).